Splenic marginal zone lymphoma surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(7 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Splenic marginal zone lymphoma}}
{{Splenic marginal zone lymphoma}}
{{CMG}}, {{AE}} {{AS}}
{{CMG}}, {{AE}}{{Affan}}, {{AS}}
==Overview==
==Overview==
The feasibility of surgery depends on the stage of splenic marginal zone lymphoma at diagnosis.  
[[Splenectomy]] was considered to be the 1st line treatment option for [[splenic marginal zone lymphoma]] ([[SMZL]]) but recent studies have shown that [[rituximab]] is equally effective if not better treatment option in terms of overall survival. [[Splenectomy]] is still performed but mainly in patients with [[splenomegaly]] without [[lymphadenopathy]] having low surgical risk or in those who are refractory to [[rituximab]] therapy.
 
==Surgery==
==Surgery==
* Splenectomy has been performed for the treatment of splenic marginal zone lymphoma (SMZL) over the years with a good success rate and may be delayed until the patient become symptomatic or develop cytopenia.<ref name="pmid12141954">{{cite journal |vauthors=Thieblemont C, Felman P, Berger F, Dumontet C, Arnaud P, Hequet O, Arcache J, Callet-Bauchu E, Salles G, Coiffier B |title=Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients |journal=Clin Lymphoma |volume=3 |issue=1 |pages=41–7 |date=June 2002 |pmid=12141954 |doi= |url=}}</ref><ref name="pmid23840125">{{cite journal |vauthors=Wu Z, Zhou J, Wang X, Li YB, Niu T, Peng B |title=Laparoscopic splenectomy for treatment of splenic marginal zone lymphoma |journal=World J. Gastroenterol. |volume=19 |issue=24 |pages=3854–60 |date=June 2013 |pmid=23840125 |pmc=3699034 |doi=10.3748/wjg.v19.i24.3854 |url=}}</ref>
* [[Splenectomy]] has been performed for the treatment of [[splenic marginal zone lymphoma]] ([[SMZL]]) over the years with a good success rate and may be delayed until the patient become [[symptomatic]] or develop [[cytopenia]].<ref name="pmid12141954">{{cite journal |vauthors=Thieblemont C, Felman P, Berger F, Dumontet C, Arnaud P, Hequet O, Arcache J, Callet-Bauchu E, Salles G, Coiffier B |title=Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients |journal=Clin Lymphoma |volume=3 |issue=1 |pages=41–7 |date=June 2002 |pmid=12141954 |doi= |url=}}</ref><ref name="pmid23840125">{{cite journal |vauthors=Wu Z, Zhou J, Wang X, Li YB, Niu T, Peng B |title=Laparoscopic splenectomy for treatment of splenic marginal zone lymphoma |journal=World J. Gastroenterol. |volume=19 |issue=24 |pages=3854–60 |date=June 2013 |pmid=23840125 |pmc=3699034 |doi=10.3748/wjg.v19.i24.3854 |url=}}</ref><ref name="pmid17680218">{{cite journal |vauthors=Matutes E |title=Splenic marginal zone lymphoma with and without villous lymphocytes |journal=Curr Treat Options Oncol |volume=8 |issue=2 |pages=109–16 |date=April 2007 |pmid=17680218 |doi=10.1007/s11864-007-0026-0 |url=}}</ref>
* Splenectomy has been used alone as well as in combination with chemotherapy regime for the treatment but no difference of overall survival benefit was found between the two therapeutic modalities.<ref name="pmid19705496">{{cite journal |vauthors=Milosevic R, Todorovic M, Balint B, Jevtic M, Krstic M, Ristanovic E, Antonijevic N, Pavlovic M, Perunicic M, Petrovic M, Mihaljevic B |title=Splenectomy with chemotherapy vs surgery alone as initial treatment for splenic marginal zone lymphoma |journal=World J. Gastroenterol. |volume=15 |issue=32 |pages=4009–15 |date=August 2009 |pmid=19705496 |pmc=2731951 |doi= |url=}}</ref>
* Response to [[splenectomy]] is partial as [[lymphocytosis]] and [[bone marrow infiltration]] persists. but it still remains a useful option for treating [[splenic marginal zone lymphoma]] ([[SMZL]]) in [[symptomatic]] patients.<ref name="pmid11180074">{{cite journal |vauthors=Franco V, Florena AM, Stella M, Rizzo A, Iannitto E, Quintini G, Campesi G |title=Splenectomy influences bone marrow infiltration in patients with splenic marginal zone cell lymphoma with or without villous lymphocytes |journal=Cancer |volume=91 |issue=2 |pages=294–301 |date=January 2001 |pmid=11180074 |doi= |url=}}</ref><ref name="pmid26989207">{{cite journal |vauthors=Arcaini L, Rossi D, Paulli M |title=Splenic marginal zone lymphoma: from genetics to management |journal=Blood |volume=127 |issue=17 |pages=2072–81 |date=April 2016 |pmid=26989207 |doi=10.1182/blood-2015-11-624312 |url=}}</ref><ref name="pmid25854936">{{cite journal |vauthors=Xing KH, Kahlon A, Skinnider BF, Connors JM, Gascoyne RD, Sehn LH, Savage KJ, Slack GW, Shenkier TN, Klasa R, Gerrie AS, Villa D |title=Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia |journal=Br. J. Haematol. |volume=169 |issue=4 |pages=520–7 |date=May 2015 |pmid=25854936 |doi=10.1111/bjh.13320 |url=}}</ref>
* Splenectomy on the other hand is considered to be a better option than chemotherapy.<ref name="pmid12614206">{{cite journal |vauthors=Parry-Jones N, Matutes E, Gruszka-Westwood AM, Swansbury GJ, Wotherspoon AC, Catovsky D |title=Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients |journal=Br. J. Haematol. |volume=120 |issue=5 |pages=759–64 |date=March 2003 |pmid=12614206 |doi= |url=}}</ref>
* [[Splenectomy]] has been used alone as well as in combination with [[chemotherapy]] regime for the treatment and no difference of overall survival benefit was found between the two therapeutic modalities. But they are  considered superior to the use of [[chemotherapy]] alone <ref name="pmid19705496">{{cite journal |vauthors=Milosevic R, Todorovic M, Balint B, Jevtic M, Krstic M, Ristanovic E, Antonijevic N, Pavlovic M, Perunicic M, Petrovic M, Mihaljevic B |title=Splenectomy with chemotherapy vs surgery alone as initial treatment for splenic marginal zone lymphoma |journal=World J. Gastroenterol. |volume=15 |issue=32 |pages=4009–15 |date=August 2009 |pmid=19705496 |pmc=2731951 |doi= |url=}}</ref><ref name="pmid12614206">{{cite journal |vauthors=Parry-Jones N, Matutes E, Gruszka-Westwood AM, Swansbury GJ, Wotherspoon AC, Catovsky D |title=Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients |journal=Br. J. Haematol. |volume=120 |issue=5 |pages=759–64 |date=March 2003 |pmid=12614206 |doi= |url=}}</ref>
 
* There is perioperative risk associated with [[splenectomy]].<ref name="pmid29043543">{{cite journal |vauthors=Kennedy ND, Lê GN, Kelly ME, Harding T, Fadalla K, Winter DC |title=Surgical management of splenic marginal zone lymphoma |journal=Ir J Med Sci |volume=187 |issue=2 |pages=343–347 |date=May 2018 |pmid=29043543 |doi=10.1007/s11845-017-1689-6 |url=}}</ref>


==References==
==References==

Latest revision as of 21:56, 30 January 2019

Splenic marginal zone lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Splenic marginal zone lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Biopsy

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Splenic marginal zone lymphoma surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Splenic marginal zone lymphoma surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Splenic marginal zone lymphoma surgery

CDC on Splenic marginal zone lymphoma surgery

Splenic marginal zone lymphoma surgery in the news

Blogs on Splenic marginal zone lymphoma surgery

Directions to Hospitals Treating Splenic marginal zone lymphoma

Risk calculators and risk factors for Splenic marginal zone lymphoma surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Muhammad Affan M.D.[2], Sowminya Arikapudi, M.B,B.S. [3]

Overview

Splenectomy was considered to be the 1st line treatment option for splenic marginal zone lymphoma (SMZL) but recent studies have shown that rituximab is equally effective if not better treatment option in terms of overall survival. Splenectomy is still performed but mainly in patients with splenomegaly without lymphadenopathy having low surgical risk or in those who are refractory to rituximab therapy.

Surgery

References

  1. Thieblemont C, Felman P, Berger F, Dumontet C, Arnaud P, Hequet O, Arcache J, Callet-Bauchu E, Salles G, Coiffier B (June 2002). "Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients". Clin Lymphoma. 3 (1): 41–7. PMID 12141954.
  2. Wu Z, Zhou J, Wang X, Li YB, Niu T, Peng B (June 2013). "Laparoscopic splenectomy for treatment of splenic marginal zone lymphoma". World J. Gastroenterol. 19 (24): 3854–60. doi:10.3748/wjg.v19.i24.3854. PMC 3699034. PMID 23840125.
  3. Matutes E (April 2007). "Splenic marginal zone lymphoma with and without villous lymphocytes". Curr Treat Options Oncol. 8 (2): 109–16. doi:10.1007/s11864-007-0026-0. PMID 17680218.
  4. Franco V, Florena AM, Stella M, Rizzo A, Iannitto E, Quintini G, Campesi G (January 2001). "Splenectomy influences bone marrow infiltration in patients with splenic marginal zone cell lymphoma with or without villous lymphocytes". Cancer. 91 (2): 294–301. PMID 11180074.
  5. Arcaini L, Rossi D, Paulli M (April 2016). "Splenic marginal zone lymphoma: from genetics to management". Blood. 127 (17): 2072–81. doi:10.1182/blood-2015-11-624312. PMID 26989207.
  6. Xing KH, Kahlon A, Skinnider BF, Connors JM, Gascoyne RD, Sehn LH, Savage KJ, Slack GW, Shenkier TN, Klasa R, Gerrie AS, Villa D (May 2015). "Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia". Br. J. Haematol. 169 (4): 520–7. doi:10.1111/bjh.13320. PMID 25854936.
  7. Milosevic R, Todorovic M, Balint B, Jevtic M, Krstic M, Ristanovic E, Antonijevic N, Pavlovic M, Perunicic M, Petrovic M, Mihaljevic B (August 2009). "Splenectomy with chemotherapy vs surgery alone as initial treatment for splenic marginal zone lymphoma". World J. Gastroenterol. 15 (32): 4009–15. PMC 2731951. PMID 19705496.
  8. Parry-Jones N, Matutes E, Gruszka-Westwood AM, Swansbury GJ, Wotherspoon AC, Catovsky D (March 2003). "Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients". Br. J. Haematol. 120 (5): 759–64. PMID 12614206.
  9. Kennedy ND, Lê GN, Kelly ME, Harding T, Fadalla K, Winter DC (May 2018). "Surgical management of splenic marginal zone lymphoma". Ir J Med Sci. 187 (2): 343–347. doi:10.1007/s11845-017-1689-6. PMID 29043543.

Template:WH Template:WS